Literature DB >> 18256362

Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics.

Pawel P Wolkow1, Monika A Niewczas, Bruce Perkins, Linda H Ficociello, Boguslaw Lipinski, James H Warram, Andrzej S Krolewski.   

Abstract

Progressive renal function decline begins in one third of patients with microalbuminuria and type 1 diabetes. This study examined whether this decline is associated with elevated excretion of inflammatory markers in urine. Five inflammatory markers (IL-6, IL-8, monocyte chemoattractant protein-1, interferon-gamma-inducible protein (IP-10), and macrophage inflammatory protein-1delta) were measured in urine samples from the First Joslin Study of the Natural History of Microalbuminuria in Type 1 Diabetes, a cohort recruited in 1991. Samples were obtained from 43 participants with microalbuminuria and stable renal function (nondecliners), from 28 with microalbuminuria and early progressive renal function decline (decliners), and from 74 with normoalbuminuria and stable renal function (reference). Urinary concentrations of all five inflammatory markers were significantly higher in decliners than in nondecliners, who were similar to the reference group. Multivariate analysis revealed that those with more than two markers elevated were more than five times as likely to have early progressive decline of renal function. In contrast, serum concentrations of C-reactive protein, IL-8, and macrophage inflammatory protein-1delta did not differ between decliners and nondecliners. These results support the hypothesis that inflammatory processes in the kidney contribute to the progression of nephropathy in patients with type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18256362      PMCID: PMC2390964          DOI: 10.1681/ASN.2007050556

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  38 in total

Review 1.  Multiplexed particle-based flow cytometric assays.

Authors:  D A Vignali
Journal:  J Immunol Methods       Date:  2000-09-21       Impact factor: 2.303

2.  Glomerular filtration rate and albuminuria: twin manifestations of nephropathy in diabetes.

Authors:  Ian H de Boer; Michael W Steffes
Journal:  J Am Soc Nephrol       Date:  2007-03-14       Impact factor: 10.121

Review 3.  Role of immunocompetent cells in nonimmune renal diseases.

Authors:  B Rodríguez-Iturbe; H Pons; J Herrera-Acosta; R J Johnson
Journal:  Kidney Int       Date:  2001-05       Impact factor: 10.612

4.  Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy.

Authors:  M Shikano; H Sobajima; H Yoshikawa; T Toba; H Kushimoto; H Katsumata; M Tomita; S Kawashima
Journal:  Nephron       Date:  2000-05       Impact factor: 2.847

Review 5.  Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies.

Authors:  Stephan Segerer; Peter J Nelson; Detlef Schlöndorff
Journal:  J Am Soc Nephrol       Date:  2000-01       Impact factor: 10.121

6.  A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes.

Authors:  L J Scott; J H Warram; L S Hanna; L M Laffel; L Ryan; A S Krolewski
Journal:  Diabetes       Date:  2001-12       Impact factor: 9.461

7.  Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.

Authors:  N Banba; T Nakamura; M Matsumura; H Kuroda; Y Hattori; K Kasai
Journal:  Kidney Int       Date:  2000-08       Impact factor: 10.612

8.  Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease.

Authors:  Kathryn Elizabeth White; Rudolf William Bilous
Journal:  J Am Soc Nephrol       Date:  2000-09       Impact factor: 10.121

9.  Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy.

Authors:  T Wada; K Furuichi; N Sakai; Y Iwata; K Yoshimoto; M Shimizu; S I Takeda; K Takasawa; M Yoshimura; H Kida; K I Kobayashi; N Mukaida; T Naito; K Matsushima; H Yokoyama
Journal:  Kidney Int       Date:  2000-10       Impact factor: 10.612

Review 10.  Urinary cytokines: clinically useful markers of chronic renal disease progression?

Authors:  W Wong; A K Singh
Journal:  Curr Opin Nephrol Hypertens       Date:  2001-11       Impact factor: 2.894

View more
  67 in total

1.  Successes achieved and challenges ahead in translating biomarkers into clinical applications.

Authors:  Greg Tesch; Shashi Amur; John T Schousboe; Jeffrey N Siegel; Lawrence J Lesko; Jane P F Bai
Journal:  AAPS J       Date:  2010-03-16       Impact factor: 4.009

2.  Interleukin-6 stimulates epithelial sodium channels in mouse cortical collecting duct cells.

Authors:  Ke Li; Dehuang Guo; Haidong Zhu; Kathleen S Hering-Smith; L Lee Hamm; Jingping Ouyang; Yanbin Dong
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-26       Impact factor: 3.619

3.  Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis.

Authors:  David R W Jayne; Annette N Bruchfeld; Lorraine Harper; Matthias Schaier; Michael C Venning; Patrick Hamilton; Volker Burst; Franziska Grundmann; Michel Jadoul; István Szombati; Vladimír Tesař; Mårten Segelmark; Antonia Potarca; Thomas J Schall; Pirow Bekker
Journal:  J Am Soc Nephrol       Date:  2017-04-11       Impact factor: 10.121

Review 4.  Proteomic discovery of diabetic nephropathy biomarkers.

Authors:  Michael L Merchant; Jon B Klein
Journal:  Adv Chronic Kidney Dis       Date:  2010-11       Impact factor: 3.620

5.  Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus.

Authors:  Gudeta D Fufaa; E Jennifer Weil; Robert G Nelson; Robert L Hanson; William C Knowler; Brad H Rovin; Haifeng Wu; Jon B Klein; Theodore E Mifflin; Harold I Feldman; Ramachandran S Vasan; Paul L Kimmel; John W Kusek; Michael Mauer
Journal:  Nephrol Dial Transplant       Date:  2015-02-03       Impact factor: 5.992

Review 6.  Progressive renal decline as the major feature of diabetic nephropathy in type 1 diabetes.

Authors:  Andrzej S Krolewski; Tomohito Gohda; Monika A Niewczas
Journal:  Clin Exp Nephrol       Date:  2013-11-12       Impact factor: 2.801

Review 7.  Therapeutic approaches to diabetic nephropathy--beyond the RAS.

Authors:  Beatriz Fernandez-Fernandez; Alberto Ortiz; Carmen Gomez-Guerrero; Jesus Egido
Journal:  Nat Rev Nephrol       Date:  2014-05-06       Impact factor: 28.314

8.  CRP polymorphisms and progression of chronic kidney disease in African Americans.

Authors:  Adriana M Hung; Dana C Crawford; Marie R Griffin; Kristin Brown-Gentry; Michael S Lipkowitz; Edward D Siew; Kerri Cavanaugh; Julia B Lewis; T Alp Ikizler
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 8.237

9.  Increased secretion of IP-10 from monocytes under hyperglycemia is via the TLR2 and TLR4 pathway.

Authors:  Sridevi Devaraj; Ishwarlal Jialal
Journal:  Cytokine       Date:  2009-05-15       Impact factor: 3.861

10.  Can existing drugs approved for other indications retard renal function decline in patients with type 1 diabetes and nephropathy?

Authors:  Alessandro Doria; Monika A Niewczas; Paolo Fiorina
Journal:  Semin Nephrol       Date:  2012-09       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.